GKIM
EW icon

GW&K Investment Management’s Edwards Lifesciences EW Stock Holding History

GW&K Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43K Buy
473
+37
+8% +$3.1K ﹤0.01% 624
2026
Q1 		$35K Sell
436
-23
-5% -$1.9K ﹤0.01% 630
2025
Q4 		$39K Buy
459
+27
+6% +$2.22K ﹤0.01% 602
2025
Q3 		$34K Buy
432
+4
+0.9% +$313 ﹤0.01% 613
2025
Q2 		$33K Buy
428
+57
+15% +$4.25K ﹤0.01% 583
2025
Q1 		$27K Sell
371
-39
-10% -$2.79K ﹤0.01% 588
2024
Q4 		$30K Buy
410
+185
+82% +$12.9K ﹤0.01% 546
2024
Q3 		$15K Sell
225
-79
-26% -$5.74K ﹤0.01% 662
2024
Q2 		$28K Buy
304
+51
+20% +$4.52K ﹤0.01% 508
2024
Q1 		$24K Buy
253
+71
+39% +$5.96K ﹤0.01% 512
2023
Q4 		$14K Sell
182
-41
-18% -$2.85K ﹤0.01% 584
2023
Q3 		$15K Buy
223
+28
+14% +$2.25K ﹤0.01% 525
2023
Q2 		$18K Buy
+195
New +$16.9K ﹤0.01% 489
2022
Q3 		– Sell
-1,099
Closed -$105K – 547
2022
Q2 		$105K Buy
1,099
+20
+2% +$2.07K ﹤0.01% 355
2022
Q1 		$127K Buy
+1,079
New +$121K ﹤0.01% 341

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GW&K Investment Management's EW Position: Q2 2026 in Review

GW&K Investment Management increased its Edwards Lifesciences (EW) stake by 8.5% in Q2 2026, buying an estimated $3.1K and bringing the position to 473 shares worth $43K. The position accounts for ﹤0.01% of the portfolio, ranked #624.

GW&K Investment Management first reported a position in EW in Q1 2022 and has held it in 15 quarters since. The position peaked at $127K in Q1 2022. 1,337 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • GW&K Investment Management held 473 shares of Edwards Lifesciences worth $43K as of Q2 2026.
  • GW&K Investment Management bought 37 Edwards Lifesciences shares in Q2 2026, an estimated $3.1K.
  • Edwards Lifesciences made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #624 holding.
  • GW&K Investment Management first reported a position in Edwards Lifesciences in Q1 2022 and has held it in 15 quarters since.
  • GW&K Investment Management's Edwards Lifesciences position peaked at $127K in Q1 2022.
  • 1,337 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.